DFTX Q2 2018 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DFTXDefinium Therapeutics, Inc.

$2B

Q2 2018 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0

Gross Profit

-$6,960

Operating Income

-$472,445

Net Income

-$471,489

EPS (Diluted)

$-1.51

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$136,270

Free Cash Flow

-$136,270

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$3M

Total Liabilities

$28,274

Stockholders' Equity

$3M

Cash & Equivalents

$106,887

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$6,960	$0	—
Operating Income	-$472,445	-$413,615	-14.2%
Net Income	-$471,489	-$410,931	-14.7%